您的购物车当前为空
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM. GP(33-41) Epitope is a strong agonist of CD8 T cells from P14 TCR-transgenic mice.
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM. GP(33-41) Epitope is a strong agonist of CD8 T cells from P14 TCR-transgenic mice.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 480 | 待询 | |
| 5 mg | ¥ 1,380 | 待询 | |
| 10 mg | ¥ 2,190 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM. GP(33-41) Epitope is a strong agonist of CD8 T cells from P14 TCR-transgenic mice. |
| 分子量 | 226.98 |
| 分子式 | CTFKNVY |
| CAS No. | 161928-86-5 |
| Smiles | [C@H](CC1=CC=C(O)C=C1)(C(N[C@H](C(N[C@@H](CC2=CC=CC=C2)C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CS)=O)[C@@H](C)O)=O)C)=O)=O)CC(N)=O)=O)NC([C@@H](NC([C@@H](NC([C@H](CCCCN)N)=O)C)=O)C(C)C)=O |
| 密度 | 1.310 g/cm3 (Predicted) |
| Sequence | Lys-Ala-Val-Tyr-Asn-Phe-Ala-Thr-Cys |
| Sequence Short | KAVYNFATC |
| 存储 | Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多